Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds

Anticancer Res. 2018 May;38(5):2607-2618. doi: 10.21873/anticanres.12502.

Abstract

Throughout the world, breast cancer is among the major causes of cancer-related death and is the most common cancer found in women. The development of cancer molecular knowledge has surpassed the novel concept of cancer biology and unraveled principle targets for anticancer drug developments and treatment strategies. Metastatic breast cancer cells acquire their aggressive features through several mechanisms, including augmentation of survival, proliferation, tumorigenicity, and motility-related cellular pathways. Clearly, natural product-derived compounds have since long been recognized as an important source for anticancer drugs, several of which have been shown to have promising anti-metastasis activities by suppressing key molecular features supporting such cell aggressiveness. This review provides the essential details of breast cancer, the molecular-based insights into metastasis, as well as the effects and mechanisms of potential compounds for breast cancer therapeutic approaches. As the abilities of cancer cells to invade and metastasize are addressed as the hallmarks of cancer, compounds possessing anti-metastatic effects, together with their defined molecular drug action could benefit the development of new drugs as well as treatment strategies.

Keywords: Breast cancer; anti-metastasis compounds; metastasis; natural product; review.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use
  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Biological Products / therapeutic use
  • Breast Neoplasms / pathology*
  • Cell Adhesion
  • Drug Discovery
  • Drug Screening Assays, Antitumor
  • Epithelial-Mesenchymal Transition
  • Extracellular Matrix / pathology
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / physiology
  • Molecular Targeted Therapy
  • Neoplasm Invasiveness
  • Neoplasm Metastasis / drug therapy
  • Neoplasm Metastasis / physiopathology*
  • Neoplasm Proteins / physiology
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / physiopathology

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Biological Products
  • Intercellular Signaling Peptides and Proteins
  • Neoplasm Proteins